Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and esketamine for prevention of emergence agitation after pediatric tonsillectomy/adenoidectomy
ChiCTR2000037603Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and esketamine in Emergence agitation (EA) (4 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Postoperative agitation in children. Started Sep 2020; status: recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2000037603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037603.